TK
Therapeutic Areas
Gland Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Enoxaparin Sodium Injection | Anticoagulation | ANDA Filed |
| Bivalirudin RTU | Anticoagulation (PCI) | Launched |
| Generic Biologics Pipeline | Oncology, Immunology | Development |
| CDMO - Client Molecule A | Oncology | Phase III |
| Proprietary Novel Delivery System | Undisclosed | Research |